| Hans-Günter Meyer-Thompson | Hepatitiden
HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates.
HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates.
Lens S, Miralpeix A, Gálvez M, Martró E, González N, Rodríguez-Tajes S, Mariño Z, Saludes V, Reyes-Urueña J, Majó X, Colom J, Forns X.
JHEP Rep. 2022 Sep 13;4(12):100580. doi: 10.1016/j.jhepr.2022.100580. PMID: 36316992; PMCID: PMC9617206.